Home › Glioblastoma › Missouri
Glioblastoma clinical trials in Missouri
13 studies for Glioblastoma are looking for participants at sites in Missouri.
Cities in Missouri
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Washington University School of Medicine Siteman Cancer Center, St Louis
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07326566Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
- University of Missouri, Columbia
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07195591A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
- Washington University School of Medicine, St Louis
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT05303467SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Washington University, St Louis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 19, 2026 · NCT05303519A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Washington University School of Medicine in St. Louis, St Louis
RecruitingPhase 1/2
Up to age 25 · All sexes · Updated Sep 25, 2026 · NCT04094610Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma
- Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
- MU Health - University Hospital/Ellis Fischel Cancer Center, Columbia
- Siteman Cancer Center at West County Hospital, Creve Coeur
- and 6 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT07452458HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
- Siteman Cancer Center at Washington University, St Louis
RecruitingPhase 1
36 Months – 22 Years · All sexes · Updated Sep 4, 2026 · NCT03911388Neurosurgical Neuronavigation Using Resting State MRI and Machine Learning
- Washington University School of Medicine, St Louis
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 30, 2026 · NCT05864976Safety and Efficacy of CTX-009 With or Without CTX-471 for Recurrent Glioblastoma
- Washington University School of Medicine, St Louis
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jun 22, 2026 · NCT07392957Neoadjuvant Chemoradiotherapy With or Without Concurrent Azeliragon in Patients With Newly Diagnosed Glioblastoma
- Washington University School of Medicine, St Louis
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated May 29, 2026 · NCT06831526Sonobiopsy for Noninvasive and Sensitive Detection of Glioblastoma
- Washington University School of Medicine, St Louis
Recruiting
Ages 18 and older · All sexes · Updated May 14, 2026 · NCT05281731Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1
- Washington University School of Medicine, St Louis
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 21, 2026 · NCT07462507SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Kansas City
- Massive Bio SYNERGY-AI site, St Louis
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.